Decitabine-structure (Decitabine Structure)
Decitabine Kit
Product Images NDC 47335-361
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 47335-361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Showbox-1 (Showbox 1)
Decitabine for Injection is a cytotoxic agent that is administered through intravenous infusion. Each drug product vial contains 50 mg decitabine, and dilution is required which can be seen in the package insert. After reconstitution, the resultant solution will have a 5 mg/mL concentration and pH of 6.7-7.3. The stability of the solution is maintained when it is stored using cold infusion fluids at 2°C to 8°C (36°F 0 46°F) for up to a maximum of 7 hours before administration. Each carton contains a single-dose vial that is sterile. Usual dosage instructions and precautions can also be found in the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
